The Macamide N-3-Methoxybenzyl-Linoleamide Is a Time-Dependent Fatty Acid Amide Hydrolase (FAAH) Inhibitor
- 14 July 2013
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 48 (2) , 333-339
Abstract
The Peruvian plant Lepidium meyenii (Maca) has been shown to possess neuroprotective activity both in vitro and in vivo [1–3]. Previous studies have also demonstrated the activity of the pentane extract and its macamides, the most representative lipophilic constituents of Maca, in the endocannabinoid system as fatty acid amide hydrolase (FAAH) inhibitors. One of the most active macamides, N-3-methoxybenzyl-linoleamide [4, 5], was studied to determine its mechanism of interaction with FAAH and whether it has inhibitory activity on mono-acyl glycerol lipase (MAGL), the second enzyme responsible for endocannabinoid degradation [6]. Macamide concentrations from 1 to 100 μM were tested using FAAH and MAGL inhibitor assay methods and showed no effect on MAGL. Tests with other conditions were performed in order to characterize the inhibitory mechanism of FAAH inhibition. N-3-methoxybenzyl-linoleamide displayed significant time-dependent and dose-dependent FAAH inhibitory activity. The mechanism of inhibition was most likely irreversible or slowly reversible. These results suggest the potential application of macamides isolated from Maca as FAAH inhibitors, as they might act on the central nervous system to provide analgesic, anti-inflammatory, or neuroprotective effects, by modulating the release of neurotransmitters.Keywords
This publication has 37 references indexed in Scilit:
- Plasmodium falciparum Clearance Rates in Response to Artesunate in Malian Children With Malaria: Effect of Acquired ImmunityThe Journal of Infectious Diseases, 2013
- Endocannabinoids and traumatic brain injuryBritish Journal of Pharmacology, 2011
- Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory PainThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Mechanism of Action of Lepidium meyenii (Maca): An Explanation for Its Neuroprotective ActivityAmerican Journal of Neuroprotection and Neuroregeneration, 2011
- Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: A neuroprotective therapeutic modalityLife Sciences, 2010
- Lepidium meyenii(Maca): A Plant from the Highlands of Peru – from Tradition to ScienceResearch in Complementary Medicine, 2009
- The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 2006
- Endocannabinoids potently protect the newborn brain against AMPA‐kainate receptor‐mediated excitotoxic damageBritish Journal of Pharmacology, 2006
- New Alkamides from Maca (Lepidium meyenii)Journal of Agricultural and Food Chemistry, 2005
- Arachidonic acid derivatives as mediators of asthmaJournal of Allergy and Clinical Immunology, 1985